GB828847A
(en)
|
1956-12-14 |
1960-02-24 |
Ilford Ltd |
Improvements in or relating to cyanine dyes
|
FR1242962A
(fr)
|
1959-08-25 |
1960-10-07 |
Kodak Pathe |
Nouveau procédé pour la préparation de colorants sensibilisateurs de la série des cyanines et des mérocyanines et produits obtenus
|
GB1268773A
(en)
|
1968-03-15 |
1972-03-29 |
Glaxo Lab Ltd |
NOVEL alpha-CARBOLINE DERIVATIVES, THE PREPARATION THEREOF AND COMPOSITIONS CONTAINING THE SAME
|
US3710795A
(en)
|
1970-09-29 |
1973-01-16 |
Alza Corp |
Drug-delivery device with stretched, rate-controlling membrane
|
GB1429184A
(en)
|
1972-04-20 |
1976-03-24 |
Allen & Hanburys Ltd |
Physically anti-inflammatory steroids for use in aerosols
|
US4044126A
(en)
|
1972-04-20 |
1977-08-23 |
Allen & Hanburys Limited |
Steroidal aerosol compositions and process for the preparation thereof
|
USRE28819E
(en)
|
1972-12-08 |
1976-05-18 |
Syntex (U.S.A.) Inc. |
Dialkylated glycol compositions and medicament preparations containing same
|
JPS54110226A
(en)
*
|
1978-01-25 |
1979-08-29 |
Bayer Ag |
Dye
|
DE2844606A1
(de)
|
1978-10-13 |
1980-04-24 |
Bayer Ag |
Heterocyclische farbstoffe
|
US4328245A
(en)
|
1981-02-13 |
1982-05-04 |
Syntex (U.S.A.) Inc. |
Carbonate diester solutions of PGE-type compounds
|
US4410545A
(en)
|
1981-02-13 |
1983-10-18 |
Syntex (U.S.A.) Inc. |
Carbonate diester solutions of PGE-type compounds
|
US4358603A
(en)
|
1981-04-16 |
1982-11-09 |
Syntex (U.S.A.) Inc. |
Acetal stabilized prostaglandin compositions
|
US4409239A
(en)
|
1982-01-21 |
1983-10-11 |
Syntex (U.S.A.) Inc. |
Propylene glycol diester solutions of PGE-type compounds
|
GB9222253D0
(en)
*
|
1992-10-23 |
1992-12-09 |
Celltech Ltd |
Chemical compounds
|
GB9304920D0
(en)
*
|
1993-03-10 |
1993-04-28 |
Celltech Ltd |
Chemical compounds
|
BR9609617B1
(pt)
*
|
1995-07-06 |
2010-07-27 |
|
derivados de 7h-pirrol[2,3-d]pirimidina, e composição farmacêutica.
|
US6716575B2
(en)
*
|
1995-12-18 |
2004-04-06 |
Sugen, Inc. |
Diagnosis and treatment of AUR1 and/or AUR2 related disorders
|
CA2239692C
(en)
|
1995-12-18 |
2008-12-16 |
Sugen, Inc. |
Diagnosis and treatment of aur-1 and/or aur-2 related disorders
|
US7119174B2
(en)
|
1995-12-18 |
2006-10-10 |
Sugen, Inc. |
Diagnosis and treatment of AUR1 and/or AUR2 related disorders
|
GB9707800D0
(en)
|
1996-05-06 |
1997-06-04 |
Zeneca Ltd |
Chemical compounds
|
DK0923581T3
(da)
*
|
1996-08-09 |
2003-08-04 |
Boehringer Ingelheim Pharma |
4-substituerede beta-carboliner som immunmodulatorer
|
GB9622363D0
(en)
|
1996-10-28 |
1997-01-08 |
Celltech Therapeutics Ltd |
Chemical compounds
|
GB9625184D0
(en)
*
|
1996-12-04 |
1997-01-22 |
Celltech Therapeutics Ltd |
Chemical compounds
|
US6057329A
(en)
|
1996-12-23 |
2000-05-02 |
Celltech Therapeutics Limited |
Fused polycyclic 2-aminopyrimidine derivatives
|
GB9705361D0
(en)
|
1997-03-14 |
1997-04-30 |
Celltech Therapeutics Ltd |
Chemical compounds
|
US6759212B1
(en)
*
|
1997-08-15 |
2004-07-06 |
Chugai Seiyaku Kabushiki Kaisha |
Cell cycle-regulating proteins
|
DE69838172T2
(de)
|
1997-08-22 |
2008-04-10 |
Astrazeneca Ab |
Oxindolylchinazolinderivate als angiogenesehemmer
|
US7462605B2
(en)
*
|
1998-01-23 |
2008-12-09 |
Celmed Oncology (Usa), Inc. |
Phosphoramidate compounds and methods of use
|
US6143480A
(en)
|
1998-09-03 |
2000-11-07 |
Fuji Photo Film Co., Ltd. |
Leuco dye and image recording medium containing the same
|
US6706491B1
(en)
*
|
1999-04-09 |
2004-03-16 |
The Board Of Trustees Of The University Of Illinois |
Reagents and methods for identifying and modulating expression of genes regulated by p21
|
US20050113460A1
(en)
*
|
1999-04-30 |
2005-05-26 |
The Regents Of The University Of Michigan |
Compositions and methods relating to novel compounds and targets thereof
|
US6982265B1
(en)
|
1999-05-21 |
2006-01-03 |
Bristol Myers Squibb Company |
Pyrrolotriazine inhibitors of kinases
|
JP2003505064A
(ja)
|
1999-07-21 |
2003-02-12 |
ユニバーシティー オブ マサチューセッツ |
キナーゼ遮断ポリペプチド及びその使用
|
AU6473600A
(en)
|
1999-08-23 |
2001-03-19 |
Shionogi & Co., Ltd. |
Pyrrolotriazine derivatives having spla2-inhibitory activities
|
GB9922171D0
(en)
|
1999-09-21 |
1999-11-17 |
Zeneca Ltd |
Chemical compounds
|
WO2001021596A1
(en)
|
1999-09-21 |
2001-03-29 |
Astrazeneca Ab |
Quinazoline derivatives and their use as pharmaceuticals
|
GB9922173D0
(en)
|
1999-09-21 |
1999-11-17 |
Zeneca Ltd |
Chemical compounds
|
HUP0204413A3
(en)
|
1999-09-21 |
2003-07-28 |
Astrazeneca Ab |
Quinazoline compounds, their preparation, their use and pharmaceutical compositions containing them
|
AU770600B2
(en)
|
1999-10-07 |
2004-02-26 |
Amgen, Inc. |
Triazine kinase inhibitors
|
US6455525B1
(en)
|
1999-11-04 |
2002-09-24 |
Cephalon, Inc. |
Heterocyclic substituted pyrazolones
|
EA005212B1
(ru)
|
1999-12-24 |
2004-12-30 |
Авентис Фарма Лимитед |
Азаиндолы
|
WO2001055116A2
(en)
|
2000-01-28 |
2001-08-02 |
Astrazeneca Ab |
Quinoline derivatives and their use as aurora 2 kinase inhibitors
|
JP4739632B2
(ja)
|
2000-02-05 |
2011-08-03 |
バーテックス ファーマシューティカルズ インコーポレイテッド |
Erkのインヒビターとして有用なピラゾール組成物
|
EP1200422A2
(de)
*
|
2000-02-05 |
2002-05-02 |
Vertex Pharmaceuticals Incorporated |
Pyrazole enthaltende zusammensetzungen und ihre verwendung als erk-inhibitoren
|
NZ521386A
(en)
*
|
2000-03-15 |
2004-06-25 |
Aventis Pharma Gmbh |
Substituted beta-carbolines with lkB-kinase inhibiting activity
|
EP1134221A1
(de)
|
2000-03-15 |
2001-09-19 |
Aventis Pharma Deutschland GmbH |
Substituierte beta-Carboline als lkB-Kinasehemmer
|
EP1209158A1
(de)
|
2000-11-18 |
2002-05-29 |
Aventis Pharma Deutschland GmbH |
Substitutierte beta-Carboline
|
JP2001294772A
(ja)
|
2000-04-10 |
2001-10-23 |
Fuji Photo Film Co Ltd |
着色組成物、インクジェット用インク及びインクジェット記録方法
|
JP2001302667A
(ja)
*
|
2000-04-28 |
2001-10-31 |
Bayer Ag |
イミダゾピリミジン誘導体およびトリアゾロピリミジン誘導体
|
US6555329B2
(en)
*
|
2000-06-09 |
2003-04-29 |
Boehringer Ingelheim International Gmbh |
Method for identifying compounds altering higher-order chromatin-dependent chromosome stability
|
US6335342B1
(en)
|
2000-06-19 |
2002-01-01 |
Pharmacia & Upjohn S.P.A. |
Azaindole derivatives, process for their preparation, and their use as antitumor agents
|
PL360439A1
(en)
|
2000-06-28 |
2004-09-06 |
Astrazeneca Ab |
Substituted quinazoline derivatives and their use as inhibitors
|
AU2002222933A1
(en)
|
2000-07-13 |
2002-01-30 |
Millennium Pharamaceuticals, Inc. |
Inhibitors of factor xa
|
US20050009876A1
(en)
*
|
2000-07-31 |
2005-01-13 |
Bhagwat Shripad S. |
Indazole compounds, compositions thereof and methods of treatment therewith
|
BR0113176A
(pt)
|
2000-08-10 |
2003-06-17 |
Pharmacia Italia Spa |
Compostos biciclo-pirazol, composições farmacêuticas compreendendo os compostos, uso dos compostos na fabricação de medicamentos, processos para a preparação dos compostos, coleção quìmica combinatória e métodos para o tratamento de mamìferos incluindo humanos utilizando os compostos
|
US6352858B1
(en)
*
|
2000-09-11 |
2002-03-05 |
Isis Pharmaceuticals, Inc. |
Antisense modulation of BTAK expression
|
US6613776B2
(en)
*
|
2000-09-15 |
2003-09-02 |
Vertex Pharmaceuticals Incorporated |
Pyrazole compounds useful as protein kinase inhibitors
|
US6660731B2
(en)
*
|
2000-09-15 |
2003-12-09 |
Vertex Pharmaceuticals Incorporated |
Pyrazole compounds useful as protein kinase inhibitors
|
US7473691B2
(en)
*
|
2000-09-15 |
2009-01-06 |
Vertex Pharmaceuticals Incorporated |
Pyrazole compounds useful as protein kinase inhibitors
|
US6610677B2
(en)
*
|
2000-09-15 |
2003-08-26 |
Vertex Pharmaceuticals Incorporated |
Pyrazole compounds useful as protein kinase inhibitors
|
DE60120193T2
(de)
|
2000-09-15 |
2007-03-29 |
Vertex Pharmaceuticals Inc., Cambridge |
Pyrazolverbindungen als protein-kinasehemmer
|
US6455559B1
(en)
|
2001-07-19 |
2002-09-24 |
Pharmacia Italia S.P.A. |
Phenylacetamido-pyrazole derivatives, process for their preparation and their use as antitumor agents
|
AU2002215053A1
(en)
*
|
2000-11-27 |
2002-06-24 |
Pharmacia Italia S.P.A. |
Phenylacetamido- pyrazole derivatives and their use as antitumor agents
|
EA005859B1
(ru)
|
2000-11-28 |
2005-06-30 |
Пфайзер Продактс Инк. |
Соли изотиазол-4-карбоксамида и их применение в качестве антигиперпролиферативных агентов
|
WO2002050079A1
(fr)
*
|
2000-12-20 |
2002-06-27 |
Societe De Conseils De Recherches Et D'applications Scientifiques (S.C.R.A.S.) |
Inhibiteurs de kinases dependantes des cylines (cdk) et de la glycogene synthase kinase-3 (gsk-3)
|
FR2818278B1
(fr)
|
2000-12-20 |
2003-02-28 |
Sod Conseils Rech Applic |
Inhibiteurs de kinases dependantes des cyclines (cdk) et de la glycogene synthase kinase-3 (gsk-3)
|
ATE528303T1
(de)
|
2000-12-21 |
2011-10-15 |
Vertex Pharma |
Pyrazoleverbindungen als proteinkinasehemmer
|
GB0102687D0
(en)
|
2001-02-02 |
2001-03-21 |
Pharmacia & Upjohn Spa |
Oxazolyl-pyrazole derivatives active as kinase inhibitors,process for their preparation and pharmaceutical compositions comprising them
|
MY130778A
(en)
|
2001-02-09 |
2007-07-31 |
Vertex Pharma |
Heterocyclic inhibitiors of erk2 and uses thereof
|
US6864255B2
(en)
|
2001-04-11 |
2005-03-08 |
Amgen Inc. |
Substituted triazinyl amide derivatives and methods of use
|
HU229867B1
(en)
*
|
2001-05-14 |
2014-10-28 |
Pfizer Prod Inc |
Tartrate salts of 5,8,14-triazatetracyclo[10.3.1.02,11.04,9]-hexadeca-2(11),3,5,7,9-pentaene and pharmaceutical compositions thereof
|
CN1511151A
(zh)
*
|
2001-05-24 |
2004-07-07 |
֮����ҩ��ʽ���� |
3-喹啉-2(1h)-亚基二氢吲哚-2-酮衍生物
|
US20030208067A1
(en)
|
2001-05-30 |
2003-11-06 |
Cao Sheldon Xiaodong |
Inhibitors of protein kinase for the treatment of disease
|
US6762179B2
(en)
*
|
2001-05-31 |
2004-07-13 |
Vertex Pharmaceuticals Incorporated |
Thiazole compounds useful as inhibitors of protein kinase
|
JP4523271B2
(ja)
|
2001-06-01 |
2010-08-11 |
バーテックス ファーマシューティカルズ インコーポレイテッド |
プロテインキナーゼのインヒビターとして有用なチアゾール化合物
|
GB0115109D0
(en)
*
|
2001-06-21 |
2001-08-15 |
Aventis Pharma Ltd |
Chemical compounds
|
CA2447885C
(en)
|
2001-06-22 |
2009-05-12 |
The Procter & Gamble Company |
Fabric care compositions for lipophilic fluid systems
|
GB0115393D0
(en)
|
2001-06-23 |
2001-08-15 |
Aventis Pharma Ltd |
Chemical compounds
|
IL159570A0
(en)
|
2001-07-19 |
2004-06-01 |
Pharmacia Italia Spa |
Phenylacetamido-thiazole derivatives, process for their preparation and their use as antitumor agents
|
US20040235867A1
(en)
|
2001-07-24 |
2004-11-25 |
Bilodeau Mark T. |
Tyrosine kinase inhibitors
|
US6872533B2
(en)
*
|
2001-07-27 |
2005-03-29 |
The Regents Of The University Of California |
STK15 (STK6) gene polymorphism and methods of determining cancer risk
|
WO2003011287A1
(en)
|
2001-08-03 |
2003-02-13 |
Vertex Pharmaceuticals Incorporated |
Pyrazolon derivatives as inhibitors of gsk-3
|
MXPA04000920A
(es)
*
|
2001-08-06 |
2004-04-02 |
Pharmacia Italia Spa |
Derivados de aminoisoxazol activos como inhibidores de la cinasa.
|
US20030073692A1
(en)
*
|
2001-08-07 |
2003-04-17 |
Pharmacia & Upjohn S.P.A. |
Amino-phthalazinone derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions containing them
|
US6927293B2
(en)
|
2001-08-30 |
2005-08-09 |
Merck & Co., Inc. |
Tyrosine kinase inhibitors
|
US6806272B2
(en)
|
2001-09-04 |
2004-10-19 |
Boehringer Ingelheim Pharma Kg |
Dihydropteridinones, processes for preparing them and their use as pharmaceutical compositions
|
EP1427707A1
(de)
|
2001-09-19 |
2004-06-16 |
Pharmacia Corporation |
Substituierte indazol verbindungen zur behandlung von entzündungen
|
CA2460942A1
(en)
|
2001-09-19 |
2003-03-27 |
Pharmacia Corporation |
Substituted pyrazolyl compounds for the treatment of inflammation
|
MXPA04002683A
(es)
*
|
2001-09-19 |
2004-06-18 |
Pharmacia Corp |
Compuestos bencenosulfamida pirazolil sustituidos para el tratamiento de la inflamacion.
|
WO2003024936A1
(en)
*
|
2001-09-19 |
2003-03-27 |
Pharmacia Corporation |
Substituted pyrazolo compounds for the treatment of inflammation
|
MXPA04001114A
(es)
|
2001-09-26 |
2004-05-20 |
Pharmacia Italia Spa |
Derivados de aminoindazol activos como inhibidores de cinasa, procedimientos para su preparacion y composiciones farmaceuticas que los contienen.
|
GB0124299D0
(en)
|
2001-10-10 |
2001-11-28 |
Astrazeneca Ab |
Crystal structure of enzyme and uses thereof
|
EP1438053B1
(de)
|
2001-10-17 |
2008-09-10 |
Boehringer Ingelheim Pharma GmbH & Co.KG |
Pyrimidinderivate, arzneimittel enthaltend diese verbindungen, deren verwendung und verfahren zu ihrer herstellung
|
US20040010027A1
(en)
|
2001-12-17 |
2004-01-15 |
Pharmacia & Upjohn Spa |
Hydroxphenyl-pyrazole derivatives active as kinase inhibitors, process for their preparation and pharmaceutical comositions comprising them
|
SE0104340D0
(sv)
|
2001-12-20 |
2001-12-20 |
Astrazeneca Ab |
New compounds
|
CA2471577C
(en)
*
|
2001-12-24 |
2011-08-02 |
Astrazeneca Ab |
Chemical compounds
|
US20050026868A1
(en)
|
2003-07-11 |
2005-02-03 |
Metcalf Chester A. |
Phosphorus-containing macrocycles
|
US20030220297A1
(en)
|
2002-02-01 |
2003-11-27 |
Berstein David L. |
Phosphorus-containing compounds and uses thereof
|
FR2836914B1
(fr)
*
|
2002-03-11 |
2008-03-14 |
Aventis Pharma Sa |
Indazoles substitues, compositions les contenant, procede de fabrication et utilisation
|
WO2003078423A1
(en)
*
|
2002-03-15 |
2003-09-25 |
Vertex Pharmaceuticals, Inc. |
Compositions useful as inhibitors of protein kinases
|
DE60332604D1
(de)
*
|
2002-03-15 |
2010-07-01 |
Vertex Pharma |
Azolylaminoazine als proteinkinasehemmer
|
US7091343B2
(en)
*
|
2002-03-15 |
2006-08-15 |
Vertex Pharmaceuticals Incorporated |
Compositions useful as inhibitors of protein kinases
|
US7179826B2
(en)
*
|
2002-03-15 |
2007-02-20 |
Vertex Pharmaceuticals Incorporated |
Compositions useful as inhibitors of protein kinases
|
SE0200979D0
(sv)
|
2002-03-28 |
2002-03-28 |
Astrazeneca Ab |
New compounds
|
WO2003086403A1
(en)
|
2002-04-08 |
2003-10-23 |
Merck & Co., Inc. |
Inhibitors of akt activity
|
WO2003087395A2
(en)
|
2002-04-15 |
2003-10-23 |
Inserm |
Methods to identify anti-tumoral agents inhibiting rasgap / aurora kinase interactions
|
WO2003091246A1
(en)
|
2002-04-26 |
2003-11-06 |
Vertex Pharmaceuticals Incorporated |
Pyrrole derivatives as inhibitors of erk2 and uses thereof
|
ES2340475T3
(es)
|
2002-05-01 |
2010-06-04 |
Vertex Pharmaceuticals Incorporated |
Estructura cristalizada de proteina aurora-2 y sus bolsillos de union.
|
AU2003227741A1
(en)
|
2002-05-17 |
2003-12-02 |
Pharmacia Italia S.P.A. |
Aminoindazole derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them
|
AU2003241907A1
(en)
|
2002-05-31 |
2003-12-19 |
Yamanouchi Pharmaceutical Co., Ltd. |
Tetrahydropyran derivative
|
US6989451B2
(en)
*
|
2002-06-04 |
2006-01-24 |
Valeant Research & Development |
Heterocyclic compounds and uses thereof
|
WO2003107002A1
(ja)
|
2002-06-12 |
2003-12-24 |
株式会社アクシアバイオサイエンス |
chfrタンパク質により触媒されるオーロラキナーゼA及びオーロラキナーゼBのポリユビキチン化反応
|
FR2840905B1
(fr)
|
2002-06-12 |
2006-07-07 |
Centre Nat Rech Scient |
Anticorps monoclonal anti-aurora-a, son procede d'obtention, et ses utilisations dans le diagnostic et le traitement des cancers
|
EP1515949B1
(de)
|
2002-06-14 |
2007-03-14 |
Merck & Co., Inc. |
Inhibitoren von mitotischem kinesin
|
MY141867A
(en)
*
|
2002-06-20 |
2010-07-16 |
Vertex Pharma |
Substituted pyrimidines useful as protein kinase inhibitors
|
US7361665B2
(en)
*
|
2002-07-09 |
2008-04-22 |
Vertex Pharmaceuticals Incorporated |
Inhibitors of c-Jun N-terminal kinases (JNK) and other protein kinases
|
WO2004006838A2
(en)
|
2002-07-15 |
2004-01-22 |
Sugen, Inc. |
Novel kinases
|
AU2003254337A1
(en)
|
2002-07-17 |
2004-02-02 |
Pharmacia Italia S.P.A. |
Heterobicyclic pyrazole derivatives as kinase inhibitors
|
BR0312924A
(pt)
|
2002-07-25 |
2005-07-12 |
Pharmacia Italia Spa |
Biciclo-pirazóis ativos como inibidores de quinase, processo para sua preparação e composições farmacêuticas compreendendo os mesmos
|
BR0312913A
(pt)
|
2002-07-25 |
2005-07-12 |
Pharmacia Italia Spa |
Ativo de biciclo-pirazóis como inibidores de cinase, processo para sua preparação e composições farmacêuticas compreendendo o mesmo
|
MXPA05000946A
(es)
|
2002-07-25 |
2005-05-16 |
Pharmacia Italia Spa |
Derivados heterociclicos condensados de pirazol como inhibidores de cinasa.
|
WO2004016597A2
(en)
*
|
2002-08-14 |
2004-02-26 |
Vertex Pharmaceuticals Incorporated |
Protein kinase inhibitors and uses thereof
|
EP1543008B1
(de)
*
|
2002-09-23 |
2007-11-07 |
Schering Corporation |
Imidazopyrazine als cdk-inhibitoren
|
US20040157804A1
(en)
|
2002-10-16 |
2004-08-12 |
Gilead Sciences, Inc. |
Pre-organized tricyclic integrase inhibitor compounds
|
AU2003286711A1
(en)
|
2002-10-25 |
2004-05-13 |
Vertex Pharmaceuticals Incorporated |
Indazolinone compositions useful as kinase inhibitors
|
US20040102360A1
(en)
*
|
2002-10-30 |
2004-05-27 |
Barnett Stanley F. |
Combination therapy
|
GB0226583D0
(en)
|
2002-11-14 |
2002-12-18 |
Cyclacel Ltd |
Compounds
|
US6909001B2
(en)
|
2002-12-12 |
2005-06-21 |
Pharmacia Corporation |
Method of making tricyclic aminocyanopyridine compounds
|
UA81790C2
(uk)
|
2002-12-19 |
2008-02-11 |
Фармация Италия С.П.А. |
Заміщені піролопіразольні похідні як інгібітори кінази
|
AU2003292435A1
(en)
|
2002-12-23 |
2004-07-14 |
Astrazeneca Ab |
4- (pyridin-4-ylamino) -quinazoline derivatives as anti-tumor agents
|
EP1578755B1
(de)
|
2002-12-24 |
2007-08-22 |
AstraZeneca AB |
Phosphonooxy-chinazolin derivate und ihre pharmazeutische verwendung
|
JP2006512387A
(ja)
|
2002-12-24 |
2006-04-13 |
アストラゼネカ アクチボラグ |
化合物
|
AU2003290322A1
(en)
|
2002-12-24 |
2004-07-22 |
Astrazeneca Ab |
Quinazoline compounds
|
CL2004000016A1
(es)
|
2003-01-21 |
2005-04-15 |
Wyeth Corp |
Compuesto derivado de cloruro de 4-amino-2-butenoilo o una sal farmaceuticamente aceptable del mismo; procedimiento para preparar dicho compuesto, util como intermediario en la sintesis de compuestos inhibidores de proteina quinasa tirosina.
|
WO2004067516A1
(en)
|
2003-01-30 |
2004-08-12 |
Boehringer Ingelheim Pharmaceuticals, Inc. |
2,4-diaminopyrimidine derivatives useful as inhibitors of pkc-theta
|
WO2004070062A2
(en)
|
2003-02-04 |
2004-08-19 |
Wyeth |
Compositions and methods for diagnosing and treating cancers
|
US8404690B2
(en)
|
2003-02-14 |
2013-03-26 |
Merck Serono Sa |
Piperazine-2-carboxamide derivatives
|
US20060264493A1
(en)
|
2003-02-17 |
2006-11-23 |
Ermes Vanotti |
Tetracyclic pyrazole derivatives as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them
|
US6861422B2
(en)
*
|
2003-02-26 |
2005-03-01 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Dihydropteridinones, processes for preparing them and their use as pharmaceutical compositions
|
CN100537570C
(zh)
|
2003-02-26 |
2009-09-09 |
贝林格尔英格海姆法玛两合公司 |
二氢蝶啶酮、其制法及作为药物制剂的用途
|
AR050920A1
(es)
|
2003-03-07 |
2006-12-06 |
Astrazeneca Ab |
Enantiomeros de heterociclos fusionados seleccionados y usos de los mismos
|
BRPI0408486A
(pt)
|
2003-03-11 |
2006-04-04 |
Pharmacia Italia Spa |
derivados de biciclopirazol ativos como inibidores da cinase, processo para a sua preparação e composições farmacêuticas compreendendo-os
|
CA2522176A1
(en)
|
2003-03-13 |
2004-09-30 |
Vertex Pharmaceuticals Incorporated |
Compositions useful as protein kinase inhibitors
|
US7223766B2
(en)
|
2003-03-28 |
2007-05-29 |
Scios, Inc. |
Bi-cyclic pyrimidine inhibitors of TGFβ
|
EP1608652A1
(de)
|
2003-03-31 |
2005-12-28 |
Vernalis (Cambridge) Limited |
Pyrazolopyrimidinverbindungen und deren verwendung in der medizin
|
WO2004090106A2
(en)
|
2003-04-04 |
2004-10-21 |
Vertex Pharmaceuticals Incorporated |
Crystal structures of human pim-1 kinase protein complexes and binding pockets thereof, and uses thereof in drug design
|
JP2006522824A
(ja)
*
|
2003-04-09 |
2006-10-05 |
ミレニアム・ファーマシューティカルズ・インコーポレイテッド |
炎症性疾患を処置するために有用なβ−カルボリン
|
BRPI0409747A
(pt)
*
|
2003-04-11 |
2006-05-09 |
Glenmark Pharmaceuticals Sa |
novos compostos heterocìclicos úteis para tratamento de distúrbios inflamatórios e alérgicos, processo para sua preparação e composições farmacêuticas contendo estes
|
ATE390422T1
(de)
|
2003-04-16 |
2008-04-15 |
Astrazeneca Ab |
Quinazolin-derivate für die behandling von krebs
|
AU2004233828B2
(en)
|
2003-04-24 |
2009-05-28 |
Merck Sharp & Dohme Corp. |
Inhibitors of Akt activity
|
US7304063B2
(en)
|
2003-04-24 |
2007-12-04 |
Merck & Co., Inc. |
Inhibitors of Akt activity
|
AU2004233827B2
(en)
|
2003-04-24 |
2009-05-28 |
Merck Sharp & Dohme Corp. |
Inhibitors of Akt activity
|
WO2004096135A2
(en)
|
2003-04-24 |
2004-11-11 |
Merck & Co., Inc. |
Inhibitors of akt activity
|
US20040242559A1
(en)
|
2003-04-25 |
2004-12-02 |
Aventis Pharma S.A. |
Novel indole derivatives, preparation thereof as medicinal products and pharmaceutical compositions, and especially as KDR inhibitors
|
BRPI0409949A
(pt)
*
|
2003-05-01 |
2006-04-25 |
Bristol Myers Squibb Co |
compostos de pirazol amida aril-substituìda úteis como inibidores de cinase
|
EP1622684A4
(de)
|
2003-05-01 |
2007-07-25 |
Univ Michigan |
Zusammensetzungen und verfahren für neue verbindungen und ihre targets
|
WO2005000200A2
(en)
|
2003-05-09 |
2005-01-06 |
Sugen, Inc. |
Novel kinases
|
CA2526578C
(en)
|
2003-05-22 |
2012-01-24 |
Pharmacia Italia S.P.A. |
Pyrazolo-quinazoline derivatives, process for their preparation and their use as kinase inhibitors
|
US7345046B2
(en)
*
|
2003-05-30 |
2008-03-18 |
Chiron Corporation |
Heteroaryl-fused pyrimidinyl compounds as anticancer agents
|
ES2308182T3
(es)
|
2003-06-02 |
2008-12-01 |
Astrazeneca Ab |
Derivadosde (3-((quinazolin-4-il)amino)-1h-pirazol-1-il)acetamida y compuestos relacionados como inhibidores de quinasas aurora para el tratamiento de enfermedades proliferativas tales como el cancer.
|
TW200505452A
(en)
|
2003-06-17 |
2005-02-16 |
Astrazeneca Ab |
Chemical compounds
|
ES2339862T3
(es)
*
|
2003-06-20 |
2010-05-26 |
Novartis Vaccines And Diagnostics, Inc. |
Compuestos de piridino 1,2-a-pirimidin-4-ona como agentes anticancerosos.
|
WO2005009348A2
(en)
|
2003-06-25 |
2005-02-03 |
Ariad Pharmaceuticals, Inc. |
Substituted purine derivatives
|
GB0315657D0
(en)
|
2003-07-03 |
2003-08-13 |
Astex Technology Ltd |
Pharmaceutical compounds
|
TWI372050B
(en)
|
2003-07-03 |
2012-09-11 |
Astex Therapeutics Ltd |
(morpholin-4-ylmethyl-1h-benzimidazol-2-yl)-1h-pyrazoles
|
WO2005002571A1
(en)
|
2003-07-03 |
2005-01-13 |
Cambridge University Technical Services Ltd |
Use of aurora kinase inhibitors for reducing the resistance of cancer cells
|
PT1641775E
(pt)
|
2003-07-03 |
2009-04-23 |
Euro Celtique Sa |
Derivados de 2-piridina-alcino úteis para o tratamento da dor
|
GB0315966D0
(en)
|
2003-07-08 |
2003-08-13 |
Cyclacel Ltd |
Compounds
|
US20050032869A1
(en)
*
|
2003-07-08 |
2005-02-10 |
Pharmacia Italia S.P.A. |
Pyrazolyl-indole derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them
|
US7141568B2
(en)
*
|
2003-07-09 |
2006-11-28 |
Pfizer Italia S.R.L. |
Pyrrolo[3,4-c]pyrazole derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them
|
CA2531333A1
(en)
|
2003-07-16 |
2005-02-10 |
Janssen Pharmaceutica N.V. |
Triazolopyrimidine derivatives as glycogen synthase kinase 3 inhibitors
|
CN100549014C
(zh)
|
2003-07-16 |
2009-10-14 |
詹森药业有限公司 |
作为糖原合酶激酶3抑制剂的三唑并嘧啶衍生物
|
CA2527861A1
(en)
|
2003-07-21 |
2005-02-10 |
Applied Research Systems Ars Holding N.V. |
Alkynyl aryl carboxamides
|
US20050143371A1
(en)
*
|
2003-07-23 |
2005-06-30 |
Pharmacia Corporation |
Beta-carboline compounds and analogues thereof as mitogen-activated protein kinase-activated protein kinase-2 inhibitors
|
GEP20094676B
(en)
|
2003-07-24 |
2009-05-10 |
Euro Celtique Sa |
Piperidine compounds and pharmaceutical compositions containing them
|
US20050026984A1
(en)
*
|
2003-07-29 |
2005-02-03 |
Aventis Pharma S.A. |
Substituted thieno [2,3-c] pyrazoles and their use as medicinal products
|
US7619059B2
(en)
|
2003-07-29 |
2009-11-17 |
Life Technologies Corporation |
Bimolecular optical probes
|
AU2004261484A1
(en)
|
2003-07-30 |
2005-02-10 |
Cyclacel Limited |
2-aminophenyl-4-phenylpyrimidines as kinase inhibitors
|
EP1648887A1
(de)
|
2003-07-30 |
2006-04-26 |
Cyclacel Limited |
Pyridinylamin-pyrimidin derivate als protein kinase hemmer
|
US7094791B2
(en)
|
2003-07-31 |
2006-08-22 |
Avalon Pharmaceuticals, Inc. |
Derivatives of 3-hydroxy-pyrrole-2,4-dicarboxylic acid and uses thereof
|
US20050043346A1
(en)
*
|
2003-08-08 |
2005-02-24 |
Pharmacia Italia S.P.A. |
Pyridylpyrrole derivatives active as kinase inhibitors
|
US7279575B2
(en)
*
|
2003-08-08 |
2007-10-09 |
Pfizer Italia S.R.L. |
Pyrimidylpyrrole derivatives active as kinase inhibitors
|
JP2007512230A
(ja)
|
2003-08-20 |
2007-05-17 |
バーテックス ファーマシューティカルズ インコーポレイテッド |
プロテインキナーゼ阻害剤として有用な(4−アミノ−1,2,5−オキサジアゾール−4−イル)−ヘテロ芳香族化合物
|
AR045595A1
(es)
|
2003-09-04 |
2005-11-02 |
Vertex Pharma |
Composiciones utiles como inhibidores de proteinas quinasas
|
EP1667995A1
(de)
|
2003-09-12 |
2006-06-14 |
Applied Research Systems ARS Holding N.V. |
Benzimidazolacetonitrile
|
WO2005026156A1
(en)
|
2003-09-16 |
2005-03-24 |
Astrazeneca Ab |
Quinazoline derivatives
|
KR20070027487A
(ko)
|
2003-09-16 |
2007-03-09 |
아스트라제네카 아베 |
퀴나졸린 유도체
|
CA2538884C
(en)
|
2003-09-16 |
2010-09-21 |
Astrazeneca Ab |
Quinazoline derivatives as tyrosine kinase inhibitors
|
EP1670422A4
(de)
|
2003-09-17 |
2007-08-01 |
Sunesis Pharmaceuticals Inc |
Identifizierung von kinase-inhibitoren
|
CN1882342A
(zh)
|
2003-09-17 |
2006-12-20 |
艾科斯有限公司 |
Chk1抑制剂在控制细胞增殖中的应用
|
ATE433974T1
(de)
|
2003-09-19 |
2009-07-15 |
Gilead Sciences Inc |
Azachinolinolphosphonatverbindungen als integraseinhibitoren
|
US20050085531A1
(en)
*
|
2003-10-03 |
2005-04-21 |
Hodge Carl N. |
Thiophene-based compounds exhibiting ATP-utilizing enzyme inhibitory activity, and compositions, and uses thereof
|
JP4845736B2
(ja)
|
2003-10-14 |
2011-12-28 |
アリゾナ ボード オブ リージェンツ オン ビハーフ ザ ユニバーシティー オブ アリゾナ |
プロテインキナーゼ阻害剤
|
CN1897950A
(zh)
|
2003-10-14 |
2007-01-17 |
惠氏公司 |
稠合芳基和杂芳基衍生物及其使用方法
|
EP1678164B1
(de)
|
2003-10-14 |
2007-04-11 |
Pharmacia Corporation |
Substituierte pyrazinonverbindungen zur behandlung von entzündungen
|
AU2004283137A1
(en)
|
2003-10-17 |
2005-05-06 |
Astrazeneca Ab |
4-(pyrazol-3-ylamino) pyrimidine derivatives for use in the treatment of cancer
|
EP1678171B1
(de)
|
2003-10-21 |
2016-09-14 |
Cyclacel Limited |
2-amino-4-thiazolon-pyrimidinderivate als proteinkinaseinhibitoren
|
WO2005037797A1
(en)
|
2003-10-21 |
2005-04-28 |
Pharmacia Corporation |
Substituted pyrazole urea compounds for the treatment of inflammation
|
BRPI0415678A
(pt)
|
2003-10-23 |
2006-12-19 |
Pharmacia Corp |
compostos de pirimidina para o tratamento de inflamação
|
WO2005044270A1
(en)
|
2003-11-04 |
2005-05-19 |
4Sc Ag |
Oxadiazolopyrazine derivatives as pharmaceutically active compounds
|
JP5095216B2
(ja)
|
2003-11-14 |
2012-12-12 |
ローラス セラピューティクス インコーポレーテッド |
アリールイミダゾールおよびその抗癌剤としての使用
|
MY141220A
(en)
|
2003-11-17 |
2010-03-31 |
Astrazeneca Ab |
Pyrazole derivatives as inhibitors of receptor tyrosine kinases
|
CA2546360A1
(en)
*
|
2003-11-19 |
2005-06-09 |
Signal Pharmaceuticals, Llc |
Methods of treating diseases and disorders by targeting multiple kinases
|
FR2864084B1
(fr)
|
2003-12-17 |
2006-02-10 |
Aventis Pharma Sa |
Nouveaux derives organophosphores des indazoles et leur utilisation comme medicaments
|
AU2004313947B2
(en)
|
2003-12-17 |
2011-03-31 |
Sgx Pharmaceuticals, Inc. |
Bicyclic pyrazolo-fused compounds as protein kinase modulators
|
GB0330042D0
(en)
|
2003-12-24 |
2004-01-28 |
Pharmacia Italia Spa |
Pyrrolo [2,3-b] pyridine derivatives active as kinase inhibitors process for their preparation and pharmaceutical compositions them
|
GB0330043D0
(en)
|
2003-12-24 |
2004-01-28 |
Pharmacia Italia Spa |
Pyrrolo [2,3-b] pyridine derivatives active as kinase inhibitors process for their preparation and pharmaceutical compositions comprising them
|
EP1704416A2
(de)
|
2004-01-16 |
2006-09-27 |
Ipsogen |
Erstellung von proteinexpressionsprofilen und brustkrebsprognose
|
CA2554150A1
(en)
|
2004-01-23 |
2005-08-04 |
Chiron Corporation |
Tetrahydrocarboline compounds as anticancer agents
|
TW200526204A
(en)
|
2004-02-03 |
2005-08-16 |
Pharmacia Italia Spa |
1h-thieno[2,3-c]pyrazole derivatives useful as kinase inhibitors
|
FR2865934B1
(fr)
|
2004-02-05 |
2006-05-05 |
Sanofi Synthelabo |
Utilisation de derives d'indolizine 1,2,3 substitues, inhibiteurs des fgfs, pour la preparation de medicaments utiles pour le traitement de maladies liees a une angiogenese pathologique choroidienne
|
GB0402653D0
(en)
|
2004-02-06 |
2004-03-10 |
Cyclacel Ltd |
Compounds
|
PE20051128A1
(es)
|
2004-02-25 |
2006-01-16 |
Schering Corp |
Pirazolotriazinas como inhibidores de quinasa
|
EP1730124A4
(de)
|
2004-03-26 |
2009-04-01 |
Amphora Discovery Corp |
Bestimmte verbindungen auf triazolbasis, zusammensetzungen und anwendungen davon
|
CA2561516A1
(en)
|
2004-03-30 |
2005-10-13 |
Pfizer Products Inc. |
Combinations of signal transduction inhibitors
|
US7507826B2
(en)
|
2004-03-30 |
2009-03-24 |
Vertex Pharmaceuticals Incorporated |
Azaindoles useful as inhibitors of JAK and other protein kinases
|
FR2868421B1
(fr)
|
2004-04-01 |
2008-08-01 |
Aventis Pharma Sa |
Nouveaux benzothiazoles et leur utilisation comme medicaments
|
JP2007533753A
(ja)
|
2004-04-23 |
2007-11-22 |
タケダ サン ディエゴ インコーポレイテッド |
インドール誘導体及びキナーゼ阻害剤としてのその使用
|
WO2005117909A2
(en)
|
2004-04-23 |
2005-12-15 |
Exelixis, Inc. |
Kinase modulators and methods of use
|
TW200538453A
(en)
|
2004-04-26 |
2005-12-01 |
Bristol Myers Squibb Co |
Bicyclic heterocycles as kinase inhibitors
|
WO2005105777A1
(en)
|
2004-05-05 |
2005-11-10 |
Pharmacia & Upjohn Company Llc |
Substituted thiophene amide compounds for the treatment of inflammation
|
WO2005113494A2
(en)
|
2004-05-07 |
2005-12-01 |
Amgen Inc. |
Nitrogenated heterocyclic derivatives as protein kinase modulators and use for the treatment of angiogenesis and cancer
|
ATE381566T1
(de)
|
2004-05-14 |
2008-01-15 |
Millennium Pharm Inc |
Verbindungen und verfahren zur inhibierung der mitotischen progression durch hemmung von aurorakinase
|
WO2005118544A2
(en)
|
2004-05-18 |
2005-12-15 |
Rigel Pharmaceuticals, Inc. |
Cycloalkyl substituted pyrimidinediamine compounds and their uses
|
EP1598343A1
(de)
|
2004-05-19 |
2005-11-23 |
Boehringer Ingelheim International GmbH |
2-Arylaminopyrimidine als PLK Inhibitoren
|
JPWO2005113550A1
(ja)
|
2004-05-20 |
2008-03-27 |
三菱ウェルファーマ株式会社 |
アミノピリミジン誘導体及びその医薬としての用途
|
CA2564215A1
(en)
|
2004-05-21 |
2005-12-01 |
Chiron Corporation |
Substituted quinoline derivatives as mitotic kinesin inhibitors
|
AU2005249446A1
(en)
|
2004-05-27 |
2005-12-15 |
Vertex Pharmaceuticals Incorporated |
Biomarkers for monitoring inhibition of IMPDH pathway
|
WO2005118587A1
(en)
|
2004-06-02 |
2005-12-15 |
Takeda Pharmaceutical Company Limited |
Indole derivative and use for treatment of cancer
|
JP2008501677A
(ja)
|
2004-06-04 |
2008-01-24 |
ファイザー・プロダクツ・インク |
異常な細胞増殖を治療する方法
|
AU2005251735A1
(en)
|
2004-06-04 |
2005-12-22 |
Amphora Discovery Corporation |
Quinoline- and isoquinoline-based compounds exhibiting ATP-utilizing enzyme inhibitory activity, and compositions, and uses thereof
|
FR2871158A1
(fr)
|
2004-06-04 |
2005-12-09 |
Aventis Pharma Sa |
Indazoles substitues, compositions les contenant, procede de fabrication et utilisation
|
US20080153869A1
(en)
|
2004-06-14 |
2008-06-26 |
Bressi Jerome C |
Kinase Inhibitors
|
CN101001845A
(zh)
|
2004-06-15 |
2007-07-18 |
阿斯利康(瑞典)有限公司 |
作为抗癌药物的取代喹唑酮
|
CA2571002A1
(en)
|
2004-06-18 |
2006-01-05 |
Chiron Corporation |
N-(1-(1-benzyl-4-phenyl-1h-imidazol-2-yl)-2,2-dimethylpropyl)benzamide derivatives and related compounds as kinesin spindle protein (ksp) inhibitors for the treatment of cancer
|
DE102004029784A1
(de)
*
|
2004-06-21 |
2006-01-05 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Neue 2-Benzylaminodihydropteridinone, Verfahren zur deren Herstellung und deren Verwendung als Arzneimittel
|
RU2007102226A
(ru)
|
2004-06-23 |
2008-07-27 |
Айрм Ллк (Bm) |
Соединения и композиции в качестве ингибиторов протеинкиназы
|
US7879853B2
(en)
|
2004-06-28 |
2011-02-01 |
Bayer Schering Pharma Ag |
4,6-disubstituted pyrimidines and their use as protein kinase inhibitors
|
US7253167B2
(en)
|
2004-06-30 |
2007-08-07 |
Bristol-Myers Squibb Company |
Tricyclic-heteroaryl compounds useful as kinase inhibitors
|
WO2006007501A2
(en)
|
2004-07-01 |
2006-01-19 |
Merck & Co., Inc. |
Mitotic kinesin inhibitors
|
TW200616974A
(en)
|
2004-07-01 |
2006-06-01 |
Astrazeneca Ab |
Chemical compounds
|
US7618971B2
(en)
|
2004-07-01 |
2009-11-17 |
Merck & Co. Inc. |
Mitotic kinesin inhibitors
|
EP1781653A1
(de)
|
2004-07-05 |
2007-05-09 |
Astex Therapeutics Limited |
3,4-disubstituierte pyrazole als inhibitoren von cyclinabhängigen kinasen (cdk) oder aurora-kinase oder glycogen-synthase-3 (gsk-3)
|
CA2571937A1
(en)
|
2004-07-08 |
2006-02-09 |
Boehringer Ingelheim Pharmaceuticals, Inc. |
Pyrimidine derivatives useful as inhibitors of pkc-theta
|
JP2008505963A
(ja)
|
2004-07-12 |
2008-02-28 |
イステイチユート・デイ・リチエルケ・デイ・ビオロジア・モレコラーレ・ピ・アンジエレツテイ・エツセ・ピー・アー |
ヒストンデアセチラーゼ(hdac)の阻害剤としてのアミド誘導体
|
AU2005261501A1
(en)
|
2004-07-12 |
2006-01-19 |
Istituto Di Ricerche Di Biologia Molecolare P Angeletti Spa |
Amide derivatives as inhibitors of histone deacetylase
|
DE102004034623A1
(de)
|
2004-07-16 |
2006-02-02 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Neue 6-Formyl-tetrahydropteridine, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
|
WO2006036266A1
(en)
|
2004-07-16 |
2006-04-06 |
Sunesis Pharmaceuticals, Inc. |
Thienopyrimidines useful as aurora kinase inhibitors
|
US20080261821A1
(en)
|
2004-07-21 |
2008-10-23 |
The Regents Of Te University Of California |
Mechanism-Based Crosslinkers
|
JP2008506761A
(ja)
|
2004-07-22 |
2008-03-06 |
アステックス、セラピューティックス、リミテッド |
プロテインキナーゼ阻害剤としてのチアゾールおよびイソチアゾール誘導体
|
BRPI0513513A
(pt)
|
2004-07-22 |
2008-05-06 |
Astrazeneca Ab |
composto ou um sal farmaceuticamente aceitável do mesmo, processo para preparar o mesmo, composição farmacêutica, uso de um composto ou um sal farmaceuticamente aceitável do mesmo, e, métodos para produzir um efeito inibitório de eg5 e um efeito anticáncer em um animal de sangue quente, e para tratar carcinomas em um animal de sangue quente
|
MX2007001127A
(es)
|
2004-07-27 |
2007-07-11 |
Sgx Pharmaceuticals Inc |
Moduladores de pirrolo-piridina cinasa.
|
US20090239214A1
(en)
|
2004-07-30 |
2009-09-24 |
Hongyue Dai |
Prognosis of breast cancer patients
|
EP1797054A2
(de)
|
2004-08-02 |
2007-06-20 |
OSI Pharmaceuticals, Inc. |
Arylaminosubstituierte pyrrolopyrimidine als multikinaseinhibierende verbindungen
|
US20060141549A1
(en)
|
2004-08-03 |
2006-06-29 |
Sudipta Mahajan |
Cell-based kinase assay
|
WO2006023083A1
(en)
|
2004-08-12 |
2006-03-02 |
Merck & Co., Inc. |
Mitotic kinesin inhibitors
|
ES2401138T3
(es)
|
2004-08-13 |
2013-04-17 |
Genentech, Inc. |
Inhibidores basados en tiazol de enzimas que usan ATP
|
JP2008510013A
(ja)
|
2004-08-18 |
2008-04-03 |
メルク エンド カムパニー インコーポレーテッド |
有糸分裂キネシン阻害剤
|
EP1778669A2
(de)
|
2004-08-18 |
2007-05-02 |
Takeda San Diego, Inc. |
Kinase-inhibitoren
|
CN101076335A
(zh)
|
2004-08-18 |
2007-11-21 |
默克公司 |
有丝分裂驱动蛋白抑制剂
|
US7521457B2
(en)
|
2004-08-20 |
2009-04-21 |
Boehringer Ingelheim International Gmbh |
Pyrimidines as PLK inhibitors
|
WO2006036395A2
(en)
|
2004-08-23 |
2006-04-06 |
Merck & Co., Inc. |
Inhibitors of akt activity
|
EP1786817A1
(de)
*
|
2004-08-26 |
2007-05-23 |
Boehringer Ingelheim International GmbH |
Pteridinone als plk (polo like kinase) inhibitoren
|
EP1784406A1
(de)
|
2004-08-27 |
2007-05-16 |
Boehringer Ingelheim International GmbH |
Dihydropteridinone, verfahren zu deren herstellung und deren verwendung als arzneimittel
|
MY191349A
(en)
|
2004-08-27 |
2022-06-17 |
Bayer Pharmaceuticals Corp |
New pharmaceutical compositions for the treatment of hyper-proliferative disorders
|
EP1786265A4
(de)
|
2004-08-30 |
2009-08-19 |
Smithkline Beecham Corp |
Neue zusammensetzungen und behandlungsverfahren
|
GB0419416D0
(en)
|
2004-09-01 |
2004-10-06 |
Inst Of Ex Botany Ascr |
4-Arylazo-3,5-Diamino-Pyrazole compounds and use thereof
|
AU2005278961A1
(en)
|
2004-09-01 |
2006-03-09 |
Astrazeneca Ab |
Quinazolinone derivatives and their use as B-Raf inhibitors
|
AR050926A1
(es)
|
2004-09-03 |
2006-12-06 |
Astrazeneca Ab |
Derivados de benzamida como inhibidores de la histonadesacetilasa(hdac)
|
CN101065016A
(zh)
|
2004-09-24 |
2007-10-31 |
詹森药业有限公司 |
蛋白激酶的抑制剂咪唑并[4,5-b]吡嗪酮
|
AR050948A1
(es)
|
2004-09-24 |
2006-12-06 |
Hoffmann La Roche |
Derivados de ftalazinona; su obtencion y su utilizacion en la fabricacion de medicamentos para el tratamiento del cancer.
|
US20060069101A1
(en)
|
2004-09-27 |
2006-03-30 |
Kim Kyoung S |
Prodrugs of protein tyrosine kinase inhibitors
|
JP2008514635A
(ja)
|
2004-09-27 |
2008-05-08 |
コーザン バイオサイエンシス インコーポレイテッド |
特異的キナーゼ阻害剤
|
AU2005294575B2
(en)
|
2004-10-04 |
2011-11-24 |
Millennium Pharmaceuticals, Inc. |
Lactam compounds useful as protein kinase inhibitors
|
FR2876377B1
(fr)
|
2004-10-11 |
2007-03-16 |
Univ Claude Bernard Lyon |
Nouveaux derives de 9h-pyrido[2,3-b]indole, leur procede de preparation, ainsi que les compositions pharmaceutiques contenant de tels composes
|
ATE540935T1
(de)
|
2004-10-12 |
2012-01-15 |
Astrazeneca Ab |
Chinazolinderivate
|
KR20070063044A
(ko)
|
2004-10-15 |
2007-06-18 |
아스트라제네카 아베 |
B-raf 억제제로서의 퀴녹살린
|
WO2006046735A1
(en)
|
2004-10-29 |
2006-05-04 |
Banyu Pharmaceutical Co., Ltd. |
Novel aminopyridine derivatives having aurora a selective inhibitory action
|
WO2006050076A1
(en)
|
2004-10-29 |
2006-05-11 |
Janssen Pharmaceutica, N.V. |
Pyrimidinyl substituted fused-pyrrolyl compounds useful in treating kinase disorders
|
JP2008520745A
(ja)
|
2004-11-22 |
2008-06-19 |
バーテックス ファーマシューティカルズ インコーポレイテッド |
Rhoキナーゼの二環式阻害剤
|
GB0427917D0
(en)
|
2004-12-21 |
2005-01-26 |
Astrazeneca Ab |
Chemical compounds
|
ITPI20040099A1
(it)
|
2004-12-24 |
2005-03-24 |
Maurizio Pacini |
Sistema di realizzazione di tappeto erboso mediante micro-plantule preradicate
|
TWI427077B
(zh)
|
2004-12-30 |
2014-02-21 |
Astex Therapeutics Ltd |
吡唑化合物及其用途和含有彼之藥學組成物
|
EP1836188A1
(de)
|
2004-12-30 |
2007-09-26 |
Astex Therapeutics Limited |
Die aktivität von cdk, gsk und aurora-kinasen modullierende pyrazolderivate
|
EP1836199A1
(de)
|
2004-12-30 |
2007-09-26 |
Astex Therapeutics Limited |
Die aktivität von cdk, gsk und aurora-kinasen modullierende thiazol- und isothiazolderivate
|
GB0500492D0
(en)
|
2005-01-11 |
2005-02-16 |
Cyclacel Ltd |
Compound
|
GB0504474D0
(en)
|
2005-03-04 |
2005-04-13 |
Astrazeneca Ab |
Chemical compounds
|
GB0504475D0
(en)
|
2005-03-04 |
2005-04-13 |
Astrazeneca Ab |
Chemical compounds
|
FR2882751B1
(fr)
|
2005-03-04 |
2007-09-14 |
Aventis Pharma Sa |
Hydrazinocarbonyl-thieno[2,3-c]pyrazoles, procede de preparation, compositions les contenant et utilisation
|
FR2884821B1
(fr)
|
2005-04-26 |
2007-07-06 |
Aventis Pharma Sa |
Pyrrolopyridines substitues, compositions les contenant, procede de fabrication et utilisation
|
GB0509223D0
(en)
|
2005-05-05 |
2005-06-15 |
Chroma Therapeutics Ltd |
Enzyme inhibitors
|
GB0509227D0
(en)
|
2005-05-05 |
2005-06-15 |
Chroma Therapeutics Ltd |
Intracellular enzyme inhibitors
|
GB0509224D0
(en)
|
2005-05-05 |
2005-06-15 |
Chroma Therapeutics Ltd |
Inhibitors of intracellular enzymatic activity
|
US7541367B2
(en)
|
2005-05-31 |
2009-06-02 |
Janssen Pharmaceutica, N.V. |
3-benzoimidazolyl-pyrazolopyridines useful in treating kinase disorders
|
JP2008542433A
(ja)
*
|
2005-06-09 |
2008-11-27 |
ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング |
CDK−1インヒビターとしてのα−カルボリン
|
US8119655B2
(en)
|
2005-10-07 |
2012-02-21 |
Takeda Pharmaceutical Company Limited |
Kinase inhibitors
|
JP2010500961A
(ja)
*
|
2006-08-02 |
2010-01-14 |
武田薬品工業株式会社 |
α−カルボリン誘導体およびその製造方法
|
EP2145878A3
(de)
|
2006-10-09 |
2010-02-24 |
Takeda Pharmaceutical Company Limited |
Aurora Kinase-inhibitoren
|
CA2666130A1
(en)
|
2006-10-09 |
2008-04-17 |
Takeda San Diego, Inc. |
Kinase inhibitors
|
EP2223925A1
(de)
*
|
2006-10-09 |
2010-09-01 |
Takeda Pharmaceutical Company Limited |
Kinase-Inhibitoren
|
SG158147A1
(en)
*
|
2006-10-09 |
2010-01-29 |
Takeda Pharmaceutical |
Kinase inhibitors
|
US20090312288A1
(en)
*
|
2008-04-16 |
2009-12-17 |
Takeda Pharmaceutical Company Limited |
Kinase inhibitors
|